Sandostatin LAR 10 mg pulver och vätska till injektionsvätska, suspension clinical trials

Octreotide treatment to improve nutritional recovery after surgery for patients with esophageal or gastric cancer, a prospective randomized open label phase II study - OTIS

This study looks at whether a drug called octreotide can help people with esophageal or stomach cancer gain weight back after surgery. It measures weight changes over six months and also checks for side effects and how people feel generally.